一、前言 近年來，隨著干細(xì)胞治療、免疫細(xì)胞治療和基因編輯等基礎(chǔ)理論、技術(shù)手段和臨床醫(yī)療探索研究的不斷發(fā)展，細(xì)胞治療產(chǎn)品為一些嚴(yán)重及難治性疾病提供了新的治療思路與方法。為規(guī)范和...
發(fā)簡信
IP屬地：加州
-
細(xì)胞治療產(chǎn)品研究與評價技術(shù)指導(dǎo)原則 （試行）
-
《細(xì)胞治療產(chǎn)品研究與評價技術(shù)指導(dǎo)原則》（試行）相關(guān)問題解讀
1.制定發(fā)布《細(xì)胞治療產(chǎn)品研究與評價技術(shù)指導(dǎo)原則》的背景是什么？ 細(xì)胞治療技術(shù)是目前國際醫(yī)學(xué)前沿重點發(fā)展領(lǐng)域，它給一些人類疑難疾病的治療提供了新的希望。近年來，細(xì)胞治療領(lǐng)域不...
-
Singapore’s Tessa raises $80M for T cell therapy push
Emerging immuno-oncology player Tessa Therapeutics has raised $80 million in a financin...
-
Juno Therapeutics and Thermo Fisher Scientific Announce CAR T Manufacturing Partnership
WALTHAM, Mass.,Dec. 20, 2017/PRNewswire/ -- Juno Therapeutics (NASDAQ:JUNO) and Thermo ...
-
Juno Try to explain death related to CAR-T
The blood-brain barrier disruption appears to be “a unique mechanism within this settin...
-
WuXi AppTec Selected by IQVIA Stem Cell Center to Serve as GMP Manufacturer of Cell Therapies and others
PHILADELPHIA,Nov. 17, 2017/PRNewswire/ -- WuXi AppTec (WuXi), a leading global pharmace...
-
Seattle Children’s opens first pediatric CAR T-Cell trial dual targeting CD22 and CD19
Seattle Children’s has opened the first chimeric antigen receptor (CAR) T-cell immunoth...
-
FDA Approves Gazyva (CD-20 mab) For Advanced Follicular Lymphoma
The Food and Drug Administration (FDA) has approved Gazyva (obinutuzumab) in combinatio...
-
FDA Grants Bluebird BCMA CAR T-Cell Therapy Breakthrough Designation in Myeloma
The FDA has granted Bluebird bb2121 a breakthrough therapy designation for previously t...
-
CBMG Opens its New Shanghai GMP Facility and Joint Laboratory
SHANGHAI, China and CUPERTINO, Calif.,November 7, 2017/GlobeNewswire/ —Cellular Biomedi...
-
FDA Lifts Clinical Hold on Cellectis Phase 1 Clinical Trials with UCART123 in AML and BPDCN
November 6, 2017 – New York (N.Y.)– Cellectis (Alternext: ALCLS - Nasdaq: CLLS) a clini...
-
Eureka is hiring
We have the following position open, if you are interested and feel it would be a good ...
-
Eutilex and Huahai Enter Immuno-Oncology Partnership
SEOUL, South Korea,Nov. 6, 2017/PRNewswire/ --Eutilex Co. Ltd. today announced that it ...
-
Servier and Pfizer to Announce UCART19 Data at ASHPreliminary Results of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a First-...
-
CABS國際合作部招募志愿者/委員會委員灣區(qū)最大的華人生物協(xié)會CABS國際合作部招募志愿者/委員會委員， Chinese American Bio/Pharmaceutical Society是灣區(qū)最大的華人生物協(xié)...